Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update.

Burri E, Maillard MH, Schoepfer AM, Seibold F, Van Assche G, Rivière P, Laharie D, Manz M.

Digestion. 2020 Jan 16:1-14. doi: 10.1159/000504092. [Epub ahead of print] Review.

PMID:
31945767
2.

Management of the Elderly Inflammatory Bowel Disease Patient.

Hruz P, Juillerat P, Kullak-Ublick GA, Schoepfer AM, Mantzaris GJ, Rogler G.

Digestion. 2020 Jan 14:1-15. doi: 10.1159/000503099. [Epub ahead of print] Review.

PMID:
31935714
3.

Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding.

Restellini S, Biedermann L, Hruz P, Mottet C, Moens A, Ferrante M, Schoepfer AM.

Digestion. 2020 Jan 8:1-16. doi: 10.1159/000502886. [Epub ahead of print] Review.

PMID:
31914444
4.

Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis Therapies.

Safroneeva E, Hafner D, Kuehni CE, Zwahlen M, Trelle S, Biedermann L, Greuter T, Vavricka SR, Straumann A, Schoepfer AM.

Int Arch Allergy Immunol. 2019 Dec 19:1-10. doi: 10.1159/000504846. [Epub ahead of print]

PMID:
31865318
5.

Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.

Schoepfer A, Vavricka SR, Brüngger B, Blozik E, Bähler C.

Eur J Gastroenterol Hepatol. 2019 Dec 9. doi: 10.1097/MEG.0000000000001616. [Epub ahead of print]

PMID:
31834046
6.

Disease Progression and Outcomes of Pregnancies in Women With Eosinophilic Esophagitis.

Schreiner P, Meissgeier S, Safroneeva E, Greuter T, Rogler G, Schoepfer A, Simon D, Simon HU, Biedermann L, Straumann A.

Clin Gastroenterol Hepatol. 2019 Dec 5. pii: S1542-3565(19)31397-7. doi: 10.1016/j.cgh.2019.11.057. [Epub ahead of print]

PMID:
31812655
7.

Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.

Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group.

Dig Dis Sci. 2019 Dec 3. doi: 10.1007/s10620-019-05978-9. [Epub ahead of print]

PMID:
31797187
8.

Real-World Data on Topical Therapies and Annual Health Resource Utilization in Hospitalized Swiss Patients with Ulcerative Colitis.

Baehler C, Brüngger B, Blozik E, Vavricka SR, Schoepfer AM.

Inflamm Intest Dis. 2019 Oct;4(4):144-153. doi: 10.1159/000502205. Epub 2019 Aug 7.

9.

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.

Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A.

Gastroenterology. 2020 Jan;158(1):111-122.e10. doi: 10.1053/j.gastro.2019.09.042. Epub 2019 Oct 5.

10.

Reply.

Greuter T, Schoepfer AM, Straumann A.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2385-2386. doi: 10.1016/j.cgh.2019.04.054. No abstract available.

PMID:
31543240
11.

[Abecedary of colonic polyps].

Archanioti P, Bornand A, Sempoux C, Unger S, Schoepfer A, Robert M, David G.

Rev Med Suisse. 2019 Aug 28;15(660):1483-1487. Review. French.

PMID:
31496171
12.

Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus.

Greuter T, Maillard MH, Juillerat P, Michetti P, Seibold F, Mottet C, Zahnd N, Sauter B, Schoepfer AM, Rogler G, Vavricka SR; on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology.

Digestion. 2019 Aug 28:1-9. doi: 10.1159/000501930. [Epub ahead of print]

PMID:
31461706
13.

Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn's Disease.

Schoepfer A, Santos J, Fournier N, Schibli S, Spalinger J, Vavricka S, Safroneeva E, Aslan N, Rogler G, Braegger C, Nydegger A.

J Crohns Colitis. 2019 Sep 27;13(10):1334-1342. doi: 10.1093/ecco-jcc/jjz065.

PMID:
31002741
14.

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.

Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, Hartmann D, Bredenoord AJ, Ciriza de Los Rios C, Schubert S, Brückner S, Madisch A, Hayat J, Tack J, Attwood S, Mueller R, Greinwald R, Schoepfer A, Straumann A; International EOS-1 Study Group.

Gastroenterology. 2019 Jul;157(1):74-86.e15. doi: 10.1053/j.gastro.2019.03.025. Epub 2019 Mar 26.

15.

Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study.

Frei R, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L.

J Crohns Colitis. 2019 Sep 27;13(10):1292-1301. doi: 10.1093/ecco-jcc/jjz057.

PMID:
30854548
16.

Chronisch entzündliche Darmerkrankungen.

Schoepfer A.

Ther Umsch. 2019 Jan;75(5):253. doi: 10.1024/0040-5930/a000996. German. No abstract available.

PMID:
30700242
17.

[Epidemiology and socio-economic aspects of chronic inflammatory bowel diseases in Switzerland].

Schoepfer A, Safroneeva E.

Ther Umsch. 2019 Jan;75(5):255-259. doi: 10.1024/0040-5930/a000997. Review. German.

PMID:
30700239
18.

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

Pittet V, Michetti P, Mueller C, Braegger CP, von Känel R, Schoepfer A, Macpherson AJ, Rogler G; Swiss IBD Cohort Study Group.

Int J Epidemiol. 2019 Apr 1;48(2):385-386f. doi: 10.1093/ije/dyy298. No abstract available.

PMID:
30689927
19.

Symptom-based patient-reported outcomes in adults with eosinophilic esophagitis: value for treatment monitoring and randomized controlled trial design.

Safroneeva E, Schoepfer AM.

Curr Opin Allergy Clin Immunol. 2019 Apr;19(2):169-174. doi: 10.1097/ACI.0000000000000514.

20.

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.

Schoepfer AM, Hirano I, Coslovsky M, Roumet MC, Zwahlen M, Kuehni CE, Hafner D, Alexander JA, Dellon ES, Gonsalves N, Leung J, Bussmann C, Collins MH, Newbury RO, Smyrk TC, Woosley JT, Yang GY, Romero Y, Katzka DA, Furuta GT, Gupta SK, Aceves SS, Chehade M, Spergel JM, Falk GW, Meltzer BA, Comer GM, Straumann A, Safroneeva E; International EEsAI Study Group.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1477-1488.e10. doi: 10.1016/j.cgh.2018.11.032. Epub 2018 Nov 23.

PMID:
30476587
21.

The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.

Hedin CRH, Vavricka SR, Stagg AJ, Schoepfer A, Raine T, Puig L, Pleyer U, Navarini A, van der Meulen-de Jong AE, Maul J, Katsanos K, Kagramanova A, Greuter T, González-Lama Y, van Gaalen F, Ellul P, Burisch J, Bettenworth D, Becker MD, Bamias G, Rieder F.

J Crohns Colitis. 2019 Apr 26;13(5):541-554. doi: 10.1093/ecco-jcc/jjy191.

PMID:
30445584
22.

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.

Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES; HEROES Study Group.

Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2.

23.

Assessment of endoscopic Doppler to guide hemostasis in high risk peptic ulcer bleeding.

Kantowski M, Schoepfer AM, Settmacher U, Stallmach A, Schmidt C.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1311-1318. doi: 10.1080/00365521.2018.1509121. Epub 2018 Nov 5.

PMID:
30394134
24.

Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes.

Safroneeva E, Balsiger L, Hafner D, Kuehni CE, Zwahlen M, Trelle S, Godat S, Biedermann L, Greuter T, Vavricka S, Straumann A, Schoepfer AM.

Aliment Pharmacol Ther. 2018 Nov;48(10):1082-1090. doi: 10.1111/apt.15000.

PMID:
30375682
25.

Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.

Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T.

Am J Gastroenterol. 2019 Jan;114(1):116-126. doi: 10.1038/s41395-018-0360-9.

PMID:
30333538
26.

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.

Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L, Godat S, Nydegger A, Scharl M, Rogler G, Vavricka SR, Schoepfer AM; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2018 Nov 28;12(12):1399-1409. doi: 10.1093/ecco-jcc/jjy121.

PMID:
30165603
27.

[Functional gastrointestinal disorders: update on the Rome IV criteria].

Marx M, Maye H, Abdelrahman K, Hessler R, Moschouri E, Aslan N, Godat S, Nichita C, Wiesel P, Perez L, Schoepfer AM.

Rev Med Suisse. 2018 Aug 29;14(616):1512-1516. Review. French.

PMID:
30156785
28.

[Endoscopic ultrasound - guided biliary and pancreatic drainage: an update].

Aslan N, Schoepfer A, Robert M, David G, Moschouri E, Galasso D, Godat S.

Rev Med Suisse. 2018 Aug 29;14(616):1495-1498. French.

PMID:
30156782
29.

[Ustekinumab - Current position].

Siegmund B, Högenauer C, Novacek G, Petritsch W, Reinisch W, Schoepfer A, Schreiber S, Vavricka S, Bokemeyer B; für die IBD-Dach-Gruppe.

Z Gastroenterol. 2018 Sep;56(9):1077-1086. doi: 10.1055/a-0655-2425. Epub 2018 Aug 13. Review. German.

PMID:
30103222
30.

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Safroneeva E, Saner C, Rossel JB, Golay D, Pittet V, Godat S, Diem S, Aepli P, Sawatzki M, Borovicka J, Burgmann K, Juillerat P, Netzer P, Sendensky A, Hruz P, Girardin M, Biedermann L, Greuter T, Vavricka S, Michetti P, Mueller C, Straumann A, Schoepfer AM; Swiss EoE Cohort Study Group.

Inflamm Intest Dis. 2018 Mar;2(3):163-170. doi: 10.1159/000486131. Epub 2018 Jan 31.

31.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ.

Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6. Review.

32.

Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland.

Guilcher K, Fournier N, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1159-1167. doi: 10.1097/MEG.0000000000001197.

PMID:
29985208
33.

Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review.

Ma C, van Rhijn BD, Jairath V, Nguyen TM, Parker CE, Aceves SS, Furuta GT, Gupta SK, Katzka DA, Safroneeva E, Schoepfer AM, Straumann A, Spergel JM, Pai RK, Feagan BG, Hirano I, Dellon ES, Bredenoord AJ.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1714-1729.e3. doi: 10.1016/j.cgh.2018.06.005. Epub 2018 Jun 14.

34.

Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients.

Greuter T, Safroneeva E, Bussmann C, Biedermann L, Vavricka SR, Katzka DA, Schoepfer AM, Straumann A.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):419-428.e6. doi: 10.1016/j.cgh.2018.05.045. Epub 2018 Jun 11.

35.

Eosinophilic esophagitis: latest insights from diagnosis to therapy.

Schoepfer A, Blanchard C, Dawson H, Lucendo A, Mauro A, Ribi C, Safroneeva E, Savarino EV, Penagini R.

Ann N Y Acad Sci. 2018 Dec;1434(1):84-93. doi: 10.1111/nyas.13731. Epub 2018 May 15. Review.

PMID:
29762879
36.

Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.

Schoepfer A, Vavricka SR, Brüngger B, Reich O, Blozik E, Bähler C.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):868-875. doi: 10.1097/MEG.0000000000001160.

PMID:
29757772
37.

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group .

J Crohns Colitis. 2018 Jun 28;12(7):811-818. doi: 10.1093/ecco-jcc/jjy040.

PMID:
29617750
38.

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.

Greuter T, Franc Y, Kaelin M, Schoepfer AM, Schreiner P, Zeitz J, Scharl M, Misselwitz B, Straumann A, Vavricka SR, Rogler G, von Känel R, Biedermann L.

Therap Adv Gastroenterol. 2018 Feb 19;11:1756283X18757715. doi: 10.1177/1756283X18757715. eCollection 2018.

39.

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.

Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):612-620. doi: 10.1097/MEG.0000000000001078.

40.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.

Schoepfer AM, Simko A, Bussmann C, Safroneeva E, Zwahlen M, Greuter T, Biedermann L, Vavricka S, Godat S, Reinhard A, Saner C, Maye H, Sempoux C, Brunel C, Blanchard C, Simon D, Simon HU, Straumann A.

Am J Gastroenterol. 2018 Mar;113(3):348-357. doi: 10.1038/ajg.2017.493. Epub 2018 Jan 16.

PMID:
29336433
41.

Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Cheng K, Gupta SK, Kantor S, Kuhl JT, Aceves SS, Bonis PA, Capocelli KE, Carpenter C, Chehade M, Collins MH, Dellon ES, Falk GW, Gopal-Srivastava R, Gonsalves N, Hirano I, King EC, Leung J, Krischer JP, Mukkada VA, Schoepfer A, Spergel JM, Straumann A, Yang GY, Furuta GT, Rothenberg ME.

Transl Sci Rare Dis. 2017 Dec 18;2(3-4):141-155. doi: 10.3233/TRD-170016.

42.

[Rare vascular diseases, building dedicated multidisciplinary specialized center].

Krieger C, Baud D, Bouchardy J, Christen-Zaech S, De Buys A, Deglise S, El Ezzi O, Fresa M, Hofer M, Hohl D, Kirsch M, Lazor R, Michel P, Monney P, Munier F, Qanadli SD, Raffoul W, Aubry Rozier B, Saucy F, Schoepfer A, Saliou G, Sekarski N, Superti-Furga A, Wuerzner G, Wasserfallen JB, Mazzolai L.

Rev Med Suisse. 2017 Dec 6;13(586):2109-2115. French.

PMID:
29211369
43.

Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.

Bähler C, Vavricka SR, Schoepfer AM, Brüngger B, Reich O.

BMC Gastroenterol. 2017 Dec 2;17(1):138. doi: 10.1186/s12876-017-0681-y.

44.

Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.

Vavricka SR, Galván JA, Dawson H, Soltermann A, Biedermann L, Scharl M, Schoepfer AM, Rogler G, Prinz Vavricka MB, Terracciano L, Navarini A, Zlobec I, Lugli A, Greuter T.

J Crohns Colitis. 2018 Feb 28;12(3):347-354. doi: 10.1093/ecco-jcc/jjx158.

45.

Eosinophile Oesophagitis.

Vavricka SR, Safroneeva E, Schoepfer A.

Ther Umsch. 2017 Nov;74(6):309-315. doi: 10.1024/0040-5930/a000920. Review. German. No abstract available.

PMID:
29160749
46.

Pharmacologic Treatment of Eosinophilic Esophagitis: An Update.

Schoepfer AM, Straumann A, Safroneeva E.

Gastrointest Endosc Clin N Am. 2018 Jan;28(1):77-88. doi: 10.1016/j.giec.2017.07.007. Epub 2017 Oct 7. Review.

PMID:
29129301
47.

Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis.

Safroneeva E, Straumann A, Schoepfer AM.

Gastrointest Endosc Clin N Am. 2018 Jan;28(1):35-45. doi: 10.1016/j.giec.2017.08.001. Review.

PMID:
29129298
48.

Current concepts in eosinophilic esophagitis.

Simon D, Straumann A, Schoepfer AM, Simon HU.

Allergo J Int. 2017;26(7):258-266. doi: 10.1007/s40629-017-0037-8. Epub 2017 Sep 13. Review.

49.

Eosinophilic esophagitis: What can we learn from Crohn's disease?

Molina-Infante J, Schoepfer AM, Lucendo AJ, Dellon ES.

United European Gastroenterol J. 2017 Oct;5(6):762-772. doi: 10.1177/2050640616672953. Epub 2016 Sep 29. Review.

50.

[Management of ulcerative colitis in 2017].

Moschouri E, Hessler R, Pittet V, Velin D, Conrad C, Hahnloser D, Gié O, Michetti P, Schoepfer AM, Maillard MH.

Rev Med Suisse. 2017 Aug 30;13(572):1480-1486. French. Erratum in: Rev Med Suisse. 2017 Oct 11;13(578):1766.

PMID:
28853805

Supplemental Content

Loading ...
Support Center